Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Perry N"'
Autor:
Souleymanov, Rusty, Brennan, David J., Logie, Carmen, Allman, Dan, Craig, Shelley L., Halkitis, Perry N.
Publikováno v:
In International Journal of Drug Policy December 2019 74:181-190
Publikováno v:
In International Journal of Drug Policy May 2018 55:207-214
Autor:
Halkitis, Perry N., Singer, Stuart N.
Publikováno v:
In International Journal of Drug Policy May 2018 55:180-182
Autor:
Rusty Souleymanov, Shelley L. Craig, Carmen H. Logie, Perry N. Halkitis, Dan Allman, David J. Brennan
Publikováno v:
International Journal of Drug Policy. 74:181-190
Party-n-Play (PNP) is a social practice that refers to sex that occurs under the influence of drugs. This study critically examined the risk and pleasure discourses of gay and bisexual men who PNP to explore how epistemic shifts associated with advan
Publikováno v:
International Journal of Drug Policy. 55:207-214
Background Substance use and condomless sexual behaviours are both well studied in sexual minority men, but few researchers have used event-level data collection to examine sexualised drug use in sexual and gender minority young adults. The aim of th
Autor:
Palamar, Joseph J., Halkitis, Perry N.
Publikováno v:
In International Journal of Drug Policy 2006 17(1):23-28
Autor:
Stuart N. Singer, Perry N. Halkitis
Publikováno v:
International Journal of Drug Policy. 55:180-182
A commentary is provided on the study reported by Garrett Prestage and his colleagues, which examined the relations between mental health states, non-injection drug use and sexual risk behaviors in a cross-sectional sample of 3,017Australian gay and
Autor:
Perry N. Halkitis, Joseph J. Palamar
Publikováno v:
International Journal of Drug Policy. 17:23-28
This paper examines the use of gamma-hydroxybutyrate (GHB) among a sample of gay men in New York City, who identify GHB as their most frequently used club drug. The sample was drawn from a larger longitudinal investigation of club drug using men. The
Publikováno v:
In International Journal of Drug Policy May 2018 55:128-130